Asset Management One Co., Ltd. Alnylam Pharmaceuticals, Inc. Transaction History
Asset Management One Co., Ltd.
- $27.7 Billion
- Q3 2024
A detailed history of Asset Management One Co., Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 67,953 shares of ALNY stock, worth $16.6 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
67,953
Previous 65,696
3.44%
Holding current value
$16.6 Million
Previous $16 Million
17.09%
% of portfolio
0.07%
Previous 0.06%
Shares
28 transactions
Others Institutions Holding ALNY
# of Institutions
642Shares Held
109MCall Options Held
1.28MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA16.5MShares$4.04 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$3.09 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.34 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.28 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.21 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.1B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...